FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US

21,577 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

 

Start Prev Rows 12200 - 12400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.418.jsonKRAS_positiveactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.419.jsonAdagrasibactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.42.jsonBreast Canceractive2023-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.420.jsoncetuximab_therapyactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.421.jsonTamoxifen_therapyactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.423.jsonEndometrial Cancer Diagnosis ICD 10active2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.425.jsonEndometrial Cancer Diagnosis ICD9CMactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.426.jsonEndometrial Cancer Diagnosisactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.428.jsonLocalized_Endometerial_Stage Group SNOMEDactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.429.jsonLocalized_Endometerial_Stage Group NCIMactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.431.jsonEndometrial_Sarcoma_Tumor_Histology_excactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.432.jsonEndometrial cancer M Stage (metastatic)active2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.433.jsonEndometrial_M0_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.436.jsonPrior_therapy_Endometrialactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.437.jsonPaclitaxel_therapyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.441.jsonCarboplatin_therapyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.442.jsonDurvalumab_therapyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.444.jsonMMR_Gene_Lab_LOINCactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.447.jsonMMR_Gene_HGNCactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.449.jsonEndometrial_ Cancer N Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.451.jsonEndometrial_N0_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.453.jsonEndometrial_N1_N2_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.455.jsonEndometrial_T1_T3_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.456.jsonEndometrial_T3_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.458.jsonEndometrial_T4_Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.459.jsonEndometrial Cancer T Stageactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.46.jsonEndometrial Cancer ICD10active2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.460.jsonLocalized_Endometerial_Stage Group_SNOMED/NCIMactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.461.jsonMetastatic Sites All CRCactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.462.jsonMetastatic Sites All CRC ICD 10active2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.463.jsonMetastatic Sites All CRC ICD 9active2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.464.jsonMetastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)active2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.465.jsonNTRK Repotrectinib Molecular Variantsactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.466.jsonNTRK_Gene_rearrangmentactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.467.jsonPrior_Systemic_therapy_Repotrectinibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.468.jsonNTRK_Positiveactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.469.jsonNTRK_test_geneactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.47.jsonSystemic treatment for endometrial canceractive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.470.jsonTamoxifen_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.471.jsonToremifene_trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.472.jsonFulvestrant_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.473.jsonElacestrantactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.474.jsonAnastrozole_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.475.jsonLeuprolide_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.476.jsonAbemaciclibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.477.jsonPalbociclibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.478.jsonRibociclibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.479.jsonCarboplatin_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.48.jsonEndometrial Cancersactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.480.jsonCisplatin_Trodelvyactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.481.jsonCyclophosphamideactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.482.jsonMethotrexateactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.483.jsonGemcitabineactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.484.jsonCapecitabineactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.485.jsonEribulinactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.486.jsonDoxorubicinactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.487.jsonVinorelbineactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.488.jsonEpirubicinactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.489.jsonIxabepiloneactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.490.jsonOlaparibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.491.jsonTalazoparibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.492.jsonEntrectinibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.493.jsonlarotrectinibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.494.jsonAlpelisibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.495.jsonCapivasertibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.496.jsonPembrolizumabactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.497.jsonDostarlimabactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.498.jsonSelpercatinibactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.499.jsonEverolimusactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.500.jsonTrastuzumab_deruxtecanactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.501.jsonTest 23active2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.502.jsonAll Metastatic sites Endometrial SNOMEDactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.503.jsonAll Metastatic sites Endometrial ICD9active2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.504.jsonAll Metastatic sites Endometrial ICD10active2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.505.jsonAll Metastatic sites Endometrialactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.506.jsonCreate CRC_Cancer_T4a_Stageactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.507.jsonCreate CRC_Cancer_T4b_Stageactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.508.jsonHigh Emetogenic Risk Chemotherapyactive2025-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.510.jsonInactiveFollowupactive2025-05hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.53.jsonMMR Gene Testingactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.54.jsonMSI Highactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.55.jsonMSI Highactive2024-01hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.6.jsonOrserduactive2023-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.61.jsonStage IIB or lower and limitedactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.62.jsonStage III or higheractive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.63.jsonStage III or higheractive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.64.jsonStage III or higheractive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.65.jsonStaging Unknownactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.66.jsonStaging Unknownactive2023-11hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.67.jsonStaging Unknownactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.68.jsonJemperliactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.69.jsonUterine Sarcomaactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.7.jsonHer2 Test For Orserduactive2023-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.70.jsonTumor Histologyactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.71.jsonPlatinum based therapyactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.72.jsonPrior Therapies for Tucatinibactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.73.jsonTucatinibactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.74.jsonColorectal Cancer ICD10active2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.75.jsonColorectal Cancer ICD9active2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.76.jsonColorectal Cancer ICD9 and ICD10active2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.78.jsonAdvanced or Unresectable Colorectal Cancer Stagingactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.79.json0 to IIIB Colorectal Cancer Stagingactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.80.jsonColorectal Cancer M1 Stageactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.81.jsonRAS Genesactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.82.jsonRAS Gene Interpretation Negative LOINCactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.83.jsonRAS Gene Interpretation Negative SNOMEDactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.84.jsonRAS Gene Interpretation Negative NCMactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.85.jsonRAS Gene Negativeactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.86.jsonRAS Gene Interpretation Positive SNOMEDactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.87.jsonRAS Gene Interpretation Positive LOINCactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.88.jsonRAS Gene Positiveactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.89.jsonHer2 Testingactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.90.jsonPatient Reasonactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.91.jsonMSI High NCIactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.92.jsonMSI Low SNOMEDactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.93.jsonMSI Low LOINCactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.94.jsonMSI Low NCIactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.95.jsonMSI Lowactive2024-01hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.96.jsonMMR Deficient NCIactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.97.jsonMMR Proficient SNOMEDactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.98.jsonMMR Proficient LOINCactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.99.jsonMMR Proficient NCIactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1262.3.jsonICD9 Codes for HIV Diagnosisactive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.1.jsonInpatient Pneumonia Diagnosisactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.11.jsonChest Imaging for Pneumonia, HCPCSactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.12.jsonChest Imaging for Pneumonia Grouping Definitionactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.18.jsonICD9 Abnormal Finding on Chest Imagingactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.19.jsonICD10 Abnormal Finding on Chest Imagingactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.2.jsonICD9 Pneumonia Definitionactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.20.jsonSNOMEDCT Abnormal Finding on Chest Imagingactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.21.jsonAbnormal Finding on Chest Imagingactive2023-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.22.jsonSNOMEDCT Pneumonia Definitionactive2023-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.23.jsonCAP Concurrent Infectionsactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.24.jsonCAP Pneumonia Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.25.jsonAntibiotic Usage for CAP Diagnosisactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.27.jsonLegionella Presence by Urine Antigen or DNAactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.29.jsonBroad Spectrum Antibiotics for MDROactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.3.jsonICD10 Pneumonia Definitionactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.32.jsonCPT Transplants, Stem Cell and Solidactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.33.jsonHCPCS Transplant, Stem Cell and Solidactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.34.jsonICD10CM Transplant, Stem Cell and Solidactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.35.jsonICD10PCS Transplant, Stem Cell and Solidactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.37.jsonSNOMEDCT Transplant, Stem Cell and Solidactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.38.jsonTransplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.39.jsonAntibiotic Usage for CAP Durationactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.40.jsonCAP Sepsis Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.41.jsonCAP Respiratory Failure Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.42.jsonMRSA Organism or Substance in Lab Resultsactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.8.jsonSystemic Antimicrobialsactive2023-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.9.jsonChest Imaging for Pneumonia, CPTactive2023-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.1.jsonProblem Typeactive2025-04hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.10.jsonInformation Source for Medication Adherence HSLOCactive2024-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.11.jsonInformation Source for Medication Adherenceactive2024-03hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.14.jsonUnknown and Asked but Unknown (DAR)active2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.15.jsonYes or No SCTactive2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.16.jsonAnswer Set with Yes No and Unknownsactive2024-10hl74
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.17.jsonCommon LOINC Lab Codesactive2024-10hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.18.jsonRadiology Procedures (LOINC)active2024-10hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.21.jsonUniversal Common LOINC Lab Ordersactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.22.jsonRoute of Administration of Therapeutic Agentsactive2024-10hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.23.jsonEncounter Typeactive2025-05hl74
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.27.jsonSocial History Type (LOINC)active2025-05hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.28.jsonSocial History Typeactive2025-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.3.jsonSmoking status comprehensiveactive2024-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.4.jsonSmoking Status Type LOINCactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.5.jsonSmoking Status Pack Years SCTactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.6.jsonSmoking Status Typeactive2024-02hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.7.jsonInformation Source for Medication Adherence HL7 Role Codeactive2024-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.8.jsonInformation Source for Medication Adherence ParticpationFunctionactive2024-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.9.jsonInformation Source for Medication Adherence SCTactive2024-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.1.jsonMalnutritionactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.10.jsonFractureactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.11.jsonTransplant Diagnosesactive2025-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.13.jsonTransplant Diagnoses ICD10CMactive2025-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.14.jsonTransplant Diagnoses SNOMED CTactive2025-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.15.jsonRespiratory Proceduresactive2025-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.3.jsonDiabetesactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.4.jsonDiabetesactive2025-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.5.jsonDiabetesactive2025-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.6.jsonImmobilityactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.7.jsonSmoking statusactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.8.jsonObesityactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1272.9.jsonHormone Therapyactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1282.1.jsonDrug Intervention Not Indicated/Contraindicatedactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1282.10.jsonEndotracheal Intubationactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1282.2.jsonProcedure Not Indicated/Contraindicatedactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1282.9.jsonMechanical Circulatory Assist Deviceactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1289.1.jsonRXNormSBD0305active2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1289.2.jsonRXNormSCD0305active2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1290.4.jsonSequential Organ Failure Assessment SOFAactive2025-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.1.11.10612.jsonUnknown Nullactive2019-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.1.11.19601.jsonx_ServiceEventPerformeractive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.1.11.20549.jsonCriticality Observationactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.15.2.5.1.jsonInitial Case Report Trigger Code Result Statusactive2024-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.15.2.5.12.jsonTherapeutic Response to Medicationactive2024-08hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.1.5.9.2.jsonCodes for MDRO and CDI Summary Data LTCFactive2020-08hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.1.5.9.3.jsonNHSNPrimaryResidentServiceTypeactive2020-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.1.5.9.4.jsonCodes for Denominators for Long Term Care Locations LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.1.5.9.5.jsonCodes for Prevention Process Measures LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113883.10.20.5.1.9.1.jsonNHSNReportNoEventsMDROLTCFactive2020-08hl7